Empower Pharmacy Reviews
Large 503A/503B compounder serving prescribers nationwide
IMPORTANT: GOV Health Report is NOT a government website. This is an independent review. Consult healthcare professionals before medical decisions.
Set by your prescriber's program — not sold directly to patients
Section 1: Executive Summary
Empower Pharmacy is one of the largest compounders in the GLP-1 space, operating both 503A patient-specific and 503B outsourcing facility lines. Its GLP-1 catalog is broad: Semaglutide/Cyanocobalamin Injection, Tirzepatide/Niacinamide Injection, and orally disintegrating tablet formulations of both, including compounded Semaglutide/Methylcobalamin ODT in three strength combinations. Empower is not a telehealth service — you cannot buy from it directly. Your prescriber sends a patient-specific prescription, and Empower dispenses. Two things belong in any honest assessment. First, Empower has published clear guidance on the post-shortage regulatory landscape, including the March 2025 phase-out dates for FDA enforcement discretion on tirzepatide and semaglutide compounding. Second, Empower's record includes repeated FDA scrutiny, and in May 2025 Endpoints News reported allegations that Empower used salt forms of semaglutide rather than the base form — a practice the FDA has warned against. Empower has continued operating and expanding its catalog. Prospective patients should ask their prescriber directly about formulation and sourcing.
Documented Strengths
5 Items- 1Operates both 503A patient-specific and 503B outsourcing facility lines
- 2Broad GLP-1 catalog including injection and orally disintegrating tablet formats
- 3Multiple published strength combinations for ODT formulations
- 4Publishes substantive educational material on GLP-1s and the post-shortage regulatory landscape
- 5Established, large-scale operation with wide prescriber reach
Noted Limitations
5 Items- 1Not available directly to patients — a prescriber must send the prescription
- 2Record includes repeated FDA scrutiny reported in trade press
- 3Reported allegations in May 2025 regarding use of semaglutide salt forms
- 4Compounded products are not FDA-approved
- 5No consumer-facing pricing published
Section 2: Medications Offered
Note: Medication availability may vary. Compounded medications are not FDA-approved. Always verify current offerings directly with the provider.
Section 3: How It Works
Work with a licensed prescriber who uses Empower Pharmacy
Your prescriber evaluates you and determines whether a compounded formulation is appropriate
A patient-specific prescription is sent to Empower's 503A pharmacy
Empower compounds the preparation under its quality-control protocols
The medication ships to you, with refills routed through Empower's refill request portal
Section 4: Eligibility Requirements
- You must have a licensed prescriber willing to send a patient-specific prescription
- Must be 18 years or older
- Compounded preparations are indicated only when a prescriber determines they are clinically appropriate
- Not pregnant or breastfeeding
- U.S. resident within Empower's shipping coverage
Important: Final eligibility is determined by a licensed healthcare provider after reviewing your complete medical history.
Section 5: Potential Side Effects
WARNING: This is not a complete list. Serious side effects may occur. Seek immediate medical attention if you experience severe symptoms. Consult your healthcare provider for complete safety information.
Section 6: Service Features
Insurance & Payment
Empower Pharmacy is a compounding pharmacy serving prescribers rather than a telehealth program. Payment arrangements depend on the prescriber's program. Compounded medications are generally not covered by insurance.
Shipping Information
Empower publishes shipping coverage information on its site and ships nationwide within that coverage. Cold-chain handling applies to injectable GLP-1 preparations.
Customer Support
Empower operates a refill request portal, a practitioner portal, and a knowledge center, with contact channels for both patients and prescribers.
Cancellation Policy
Not applicable in the usual sense — Empower dispenses against prescriptions rather than selling subscriptions. Any subscription terms come from the prescriber's program.
Section 7: Additional Services
Section 8: Program Structure
Compounded. Empower's GLP-1 injections are available exclusively through its 503A compounding pharmacy pursuant to a patient-specific prescription. Compounded medications are not FDA-approved. Empower has publicly addressed the FDA's phase-out of enforcement discretion for compounded tirzepatide and semaglutide, which took effect in March 2025.
Empower does not employ prescribers or provide clinical care. Your own prescriber evaluates you, decides on a formulation, and sends the prescription. All clinical management stays with that prescriber.
Determined entirely by your prescriber. Empower sets no lab requirement.
Empower Pharmacy itself, operating 503A patient-specific and 503B outsourcing facility lines from Houston, TX.
Per prescription fill, with refills requested through Empower's portal.
Section 9: Cost Breakdown
Not applicable. Empower does not sell memberships — any fee structure comes from the prescriber's program.
Empower does not publish consumer-facing pricing. What you pay depends on the arrangement your prescriber's program has with the pharmacy.
Compounded, patient-specific preparations are generally not returnable. Confirm terms with Empower and your prescriber before ordering.
Prescription medication is commonly HSA/FSA eligible. Confirm with your plan administrator, noting that compounded medications can be treated differently by some plans.
Section 10: Documented Limitations
- You cannot order directly — a prescriber relationship is required
- Compounded medications are not FDA-approved or FDA-reviewed
- Trade press has reported repeated FDA scrutiny of the company
- Endpoints News reported in May 2025 allegations that Empower used semaglutide salt forms rather than the base form, which the FDA has warned against
- No consumer-facing pricing or program structure
Section 11: Alternatives to Consider
Another large 503A compounder serving telehealth partners.
Established compounder with a comparable prescriber-directed model.
Long-standing compounding pharmacy with GLP-1 offerings.
If you want a complete program rather than a pharmacy relationship.
Section 12: Frequently Asked Questions
Can I buy compounded semaglutide directly from Empower Pharmacy?
No. Empower's compounded GLP-1 injections are available exclusively through its 503A compounding pharmacy pursuant to a patient-specific prescription. You need a licensed prescriber who uses Empower.
What GLP-1 formulations does Empower make?
Semaglutide/Cyanocobalamin Injection, Tirzepatide/Niacinamide Injection, Tirzepatide ODT, and compounded Semaglutide/Methylcobalamin ODT in 2 mg, 5 mg, and 12 mg semaglutide strengths.
What is the difference between 503A and 503B?
A 503A pharmacy compounds against patient-specific prescriptions. A 503B outsourcing facility can produce larger batches without patient-specific prescriptions and is subject to FDA inspection and current good manufacturing practice requirements. Empower operates both.
Has Empower Pharmacy faced regulatory scrutiny?
Yes. Trade press has reported repeated FDA scrutiny, and in May 2025 Endpoints News reported allegations that Empower used salt forms of semaglutide rather than the base form — a practice the FDA has warned against. Discuss formulation and sourcing with your prescriber.
Are compounded GLP-1s still legal after the shortage ended?
Empower itself published guidance on the post-shortage era, noting the FDA's enforcement discretion for compounded tirzepatide and semaglutide phased out in March 2025. Compounding continues under 503A and 503B rules where clinically justified, but the regulatory picture has tightened considerably.
Assessment Recommendation
Best suited for: Prescribers and their patients who want a large-scale compounder with both 503A and 503B capability and a broad formulation catalog
Medical Disclaimer
This assessment is for general informational purposes only and is not medical advice, a diagnosis, or a treatment recommendation. GOV Health Report is an independent publisher, is not affiliated with any government agency, and does not practice medicine or dispense medication. GLP-1 medications are prescription drugs with serious potential risks and are not appropriate for everyone. Only a licensed clinician who has evaluated you can determine whether treatment is safe for you. Compounded medications are not FDA-approved and are not reviewed by the FDA for safety, effectiveness, or quality. Always talk to a qualified healthcare professional before starting, stopping, or changing any medication, and read our full medical disclaimer.
Date reviewed: August 5, 2026. Details on this page reflect information published by the provider as of that date and can change without notice.
Empower Pharmacy
Set by your prescriber's program — not sold directly to patients
Quick Reference
Consumer Reviews
Public submissions and ratings
No ratings yet
Rate your experience
Click a star to submit your rating
Questions & Discussions
Community forum and inquiries
Proceed to Empower Pharmacy
Assessment complete. Ready to start your consultation?
Visit Empower PharmacyAffiliate link — Commission may be earned on sign-ups